Literature DB >> 28955113

Advances in the Medical Management of Vascular Anomalies.

Kiersten W Ricci1.   

Abstract

Vascular anomalies comprise a spectrum of diseases that are broadly classified as tumors and malformations. Diagnosis is often challenging, given a wide range of clinical presentations with overlapping signs and symptoms. Accurate diagnosis is critical to determine prognosis and to generate a management plan, which frequently involves multiple subspecialists during different phases of treatment. An updated classification system provides structure and clear, consistent terminology, allowing for improved diagnosis, provider communication, and collaboration. Historically, treatment of vascular anomalies was primarily surgical and medical therapies were limited or ineffective. Recent discoveries of pharmacologic agents effective in treating vascular anomalies have broadened our medical therapeutic options, limiting the need for unnecessary or high-risk procedures and improving patients' quality of life.

Entities:  

Keywords:  interventional radiology; propranolol; sirolimus; timolol; vascular anomaly; vascular malformation

Year:  2017        PMID: 28955113      PMCID: PMC5615390          DOI: 10.1055/s-0037-1604297

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  89 in total

1.  Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.

Authors:  Beth A Drolet; Cameron C Trenor; Leonardo R Brandão; Yvonne E Chiu; Robert H Chun; Roshni Dasgupta; Maria C Garzon; Adrienne M Hammill; Craig M Johnson; Brook Tlougan; Francine Blei; Michèle David; Ravindhra Elluru; Ilona J Frieden; Sheila F Friedlander; Ionela Iacobas; John N Jensen; David M King; Margaret T Lee; Stephen Nelson; Manish Patel; Elena Pope; Julie Powell; Marcia Seefeldt; Dawn H Siegel; Michael Kelly; Denise M Adams
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

2.  Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.

Authors:  Zuopeng Wang; Kai Li; Kuiran Dong; Xianmin Xiao; Shan Zheng
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

3.  ISSVA classification.

Authors:  Roshni Dasgupta; Steven J Fishman
Journal:  Semin Pediatr Surg       Date:  2014-06-19       Impact factor: 2.754

4.  Sirolimus for the treatment of complicated vascular anomalies in children.

Authors:  Adrienne M Hammill; MarySue Wentzel; Anita Gupta; Stephen Nelson; Anne Lucky; Ravi Elluru; Roshni Dasgupta; Richard G Azizkhan; Denise M Adams
Journal:  Pediatr Blood Cancer       Date:  2011-03-28       Impact factor: 3.167

5.  Sildenafil for microcystic lymphatic malformations of the head and neck: A prospective study.

Authors:  John C Koshy; Bradley S Eisemann; Nikhil Agrawal; Sheena Pimpalwar; Joseph L Edmonds
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-04-09       Impact factor: 1.675

Review 6.  Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.

Authors:  Ciara O'Rafferty; Grainne M O'Regan; Alan D Irvine; Owen P Smith
Journal:  Br J Haematol       Date:  2015-06-30       Impact factor: 6.998

7.  Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

Authors:  S Huber; C J Bruns; G Schmid; P C Hermann; C Conrad; H Niess; R Huss; C Graeb; K-W Jauch; C Heeschen; M Guba
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

8.  Topical Timolol Maleate Treatment of Infantile Hemangiomas.

Authors:  Katherine Püttgen; Anne Lucky; Denise Adams; Elena Pope; Catherine McCuaig; Julie Powell; Dana Feigenbaum; Yulia Savva; Eulalia Baselga; Kristen Holland; Beth Drolet; Dawn Siegel; Kimberly D Morel; Maria C Garzon; Erin Mathes; Christine Lauren; Amy Nopper; Kimberly Horii; Brandon Newell; Wei Song; Ilona Frieden
Journal:  Pediatrics       Date:  2016-08-15       Impact factor: 7.124

9.  Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF.

Authors:  Damian Medici; Bjorn R Olsen
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

10.  Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.

Authors:  Thomas D Griffin; James P Foshee; Robert Finney; Nazanin Saedi
Journal:  Lasers Surg Med       Date:  2015-10-26       Impact factor: 4.025

View more
  5 in total

Review 1.  New and Emerging Targeted Therapies for Vascular Malformations.

Authors:  An Van Damme; Emmanuel Seront; Valérie Dekeuleneer; Laurence M Boon; Miikka Vikkula
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

2.  Use of Multispectral Optoacoustic Tomography to Diagnose Vascular Malformations.

Authors:  Max Masthoff; Anne Helfen; Jing Claussen; Angelos Karlas; Niklas A Markwardt; Vasilis Ntziachristos; Michel Eisenblätter; Moritz Wildgruber
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

3.  Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream.

Authors:  Katheryn A Bell; Emily L Guo; Cynthia M C DeKlotz
Journal:  JAAD Case Rep       Date:  2020-12-14

Review 4.  Atlas of Nervous System Vascular Malformations: A Systematic Review.

Authors:  Carlos Castillo-Rangel; Gerardo Marín; Karla Aketzalli Hernandez-Contreras; Cristofer Zarate-Calderon; Micheel Merari Vichi-Ramirez; Wilmar Cortez-Saldias; Marco Antonio Rodriguez-Florido; Ámbar Elizabeth Riley-Moguel; Omar Pichardo; Osvaldo Torres-Pineda; Helena G Vega-Quesada; Ramiro Lopez-Elizalde; Jaime Ordoñez-Granja; Hugo Helec Alvarado-Martinez; Luis Andrés Vega-Quesada; Gonzalo Emiliano Aranda-Abreu
Journal:  Life (Basel)       Date:  2022-08-07

Review 5.  A Primer on a Comprehensive Genetic Approach to Vascular Anomalies.

Authors:  Alexandra J Borst; Taizo A Nakano; Francine Blei; Denise M Adams; Jessica Duis
Journal:  Front Pediatr       Date:  2020-10-19       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.